Skip to main navigation Skip to search Skip to main content

Phase i trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: Translation from preclinical investigations aiming to improve the therapeutic ratio

  • Aron Popovtzer
  • , Daniel Normolle
  • , Francis P. Worden
  • , Mark E. Prince
  • , Douglas B. Chepeha
  • , Gregory T. Wolf
  • , Carol R. Bradford
  • , Theodore S. Lawrence
  • , Avraham Eisbruch*
  • *Corresponding author for this work
  • University of Michigan, Ann Arbor
  • Rabin Medical Center Israel
  • University of Pittsburgh

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: Translation from preclinical investigations aiming to improve the therapeutic ratio'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology